Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density.
Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 7000 Shoreline Court,
- Phone
- 415-429-7800
- in****@****ida.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- tricida.com
- Keywords
- Manager jobs.
- HQ
- South San Francisco, CA
Tricida, Inc. Questions
Tricida, Inc.'s helpline number is 415-429-7800
Tricida, Inc.'s website is tricida.com
Tricida, Inc.'s LinkedIn profile is https://www.linkedin.com/company/tricida-inc-
Tricida, Inc. has
12 employees.
View email and phone details for 12
employees at Tricida, Inc..
Tricida, Inc.'s industry is
Pharmaceutical Manufacturing
Tricida, Inc.'s top competitors are
Asana,
Allogene Therapeutics,
Jasper Therapeutics,
Vaxart, Inc.,
Ultragenyx,
Exelixis,
Arlo Technologies, Inc.,
Impel Pharmaceuticals,
Alumis,
Calliditas Therapeutics.
Tricida, Inc.'s support email address is info@tricida.com
Tricida, Inc.'s categories are Pharmaceutical Manufacturing
Tricida, Inc.'s founding year is 2013
